Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.33    -0.01 (-0.43%)
Bid:
2.32
Ask:
2.35
Spread: 0.03 (1.293%)
Market Cap: $752.76m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Director/PDMR Shareholding

22 Feb 2024 15:00

RNS Number : 1589E
RTW Biotech Opportunities Ltd
22 February 2024

RTW BIOTECH OPPORTUNITIES LTD

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

William Scott

2

Reason for the notification

a)

Position/status

Director of RTW Biotech Opportunities Ltd

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

RTW Biotech Opportunities Ltd

b)

LEI

549300Q7EXQQH6KF7Z84

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of no par value

GG00BKTRRM22

b)

Nature of the transaction

Purchase of Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$1.322

50,000

d)

Aggregated information

- Aggregated volume

- Price

50,000

$1.322

e)

Date of the transaction

22 February 2024

f)

Place of the transaction

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQKBBNQBKDPBB
Date   Source Headline
7th Dec 20221:00 pmRNSNew Investment in Apogee Therapeutics
1st Dec 20227:00 amRNSPublication of Circular & Convening of EGM
30th Nov 20222:00 pmRNSDirector/PDMR Shareholding
28th Nov 20227:00 amRNSChange of status for US federal tax - PTP to PFIC
14th Nov 20227:00 amRNSNet Asset Value(s)
4th Nov 20224:04 pmRNSDirector/PDMR Shareholding
1st Nov 20225:07 pmRNSDirector/PDMR Shareholding
25th Oct 20227:00 amRNSQuarterly Update
20th Oct 20227:00 amRNSEdison issues review on RTW Venture Fund (RTW)
14th Oct 20227:00 amRNSNet Asset Value(s)
22nd Sep 20227:00 amRNSDirector/PDMR Shareholding
16th Sep 20227:00 amRNSPortfolio Company Update: Third Harmonic Bio IPO
15th Sep 20227:30 amRNSNet Asset Value(s)
15th Sep 20227:00 amRNSHalf-year Report
17th Aug 202212:00 pmRNSNotice of Interim Report
12th Aug 20227:00 amRNSNet Asset Value(s)
26th Jul 20227:00 amRNSQuarterly Update
19th Jul 20227:55 amRNSAdditional Investment in Portfolio Company
15th Jul 20227:00 amRNSNet Asset Value(s)
6th Jul 20227:00 amRNSPortfolio Company Transaction Update
21st Jun 20225:33 pmRNSResult of AGM
13th Jun 20227:00 amRNSNet Asset Value(s)
17th May 20227:00 amRNSNotice of AGM
13th May 20227:00 amRNSNet Asset Value(s)
28th Apr 20227:00 amRNSQuarterly Update
14th Apr 20227:05 amRNSNew Investment
14th Apr 20227:00 amRNSNet Asset Value(s)
4th Apr 20224:23 pmRNSDirector/PDMR Shareholding
4th Apr 20224:22 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSAnnual Financial Report
14th Mar 20227:00 amRNSNet Asset Value(s)
7th Mar 20227:00 amRNSNotice of Annual Report
17th Feb 20227:50 amRNSAdditional Investment in Magnolia Medical
16th Feb 202212:45 pmRNSNew Investment in Third Harmonic Bio
14th Feb 20227:00 amRNSNet Asset Value(s)
26th Jan 20222:00 pmRNSNew Investment in Kyverna
24th Jan 20227:00 amRNSQuarterly Update
14th Jan 20227:00 amRNSNet Asset Value(s)
12th Jan 20228:05 amEQSEdison Investment Research Limited: RTW Venture Fund (RTW) - Initiation: 'One-stop shop' for biotech lifecycle investment
10th Jan 20227:00 amRNSPortfolio Company Update: CinCor Pharma IPO
14th Dec 20217:00 amRNSNet Asset Value(s)
12th Nov 20217:00 amRNSNet Asset Value(s)
26th Oct 20217:00 amRNSQuarterly Update
22nd Oct 20217:00 amRNSPortfolio Company Update: Ventyx IPO
14th Oct 20217:00 amRNSNet Asset Value(s)
13th Oct 20217:00 amRNSNew Investment in CinCor Pharma
11th Oct 20217:00 amRNSPortfolio Company Update: Pyxis IPO
1st Oct 20217:00 amRNSTotal Voting Rights
21st Sep 20217:00 amRNSDirector/PDMR Shareholding
20th Sep 20217:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.